$ETST In Marsh 2017 ETST commenced leasing the required manufacturing facility for the production of the MSN-2 medical device and began the first round of negotiations with foreign health authorities for the MSN-2’s commercialization. This product will be launched in select countries in 2018, which will be the beginning of the success story for this unique tool that will allow women to take their health needs in their own hands. It will allow women to protect themselves and their future babies from Chlamydia and other sexually transmitted infections (STI). ETST is proud to participate in the fight to counter the spread of STI and their devastating effects on the sexual organs of women.
(0)
(0)
Earth Science Tech, Inc. (ETST) Stock Research Links
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!